AAAAAA
Results: 1-25/46
Authors:
SCHOMACKER K
FISCHER T
BOTTCHER B
MRAHEEL SA
SCHARL A
GABRUKSZOSTAK B
SCHEIDHAUER K
GOHRING UJ
MELLERREHBEIN B
SHUKLA SK
SCHICHA H
Citation: K. Schomacker et al., KINETIC OF RECEPTOR-MEDIATED RADIOTOXICIT Y OF 16-ALPHA-[I-125]-IODOESTRADIOL-3,17-BETA, Nuklearmedizin, 37(4), 1998, pp. 134-140
Authors:
SCHONDORF T
ENGEL H
KURBACHER CM
BRENNE U
KOLHAGEN H
GOHRING UJ
SCHARL A
MALLMANN P
Citation: T. Schondorf et al., IMMUNOLOGICAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES IN OVARIAN-CANCER PATIENTS, Journal of the Society for Gynecologic Investigation, 5(2), 1998, pp. 102-107
Authors:
MARTIN VM
SIEWERT C
SCHARL A
HARMS T
HEINZE R
OHL S
RADBRUCH A
MILTENYI S
SCHMITZ J
Citation: Vm. Martin et al., IMMUNOMAGNETIC ENRICHMENT OF DISSEMINATED EPITHELIAL TUMOR-CELLS FROMPERIPHERAL-BLOOD BY MACS, Experimental hematology, 26(3), 1998, pp. 252-264
Authors:
CAMINADA MC
AHR A
SCHARRER I
SCHARL A
KAUFMANN M
Citation: Mc. Caminada et al., ACUTE EXACERBATED LUPUS-ERYTHEMATOSUS - D IFFERENTIAL-DIAGNOSIS OF A HELLP-SYNDROME, Geburtshilfe und Frauenheilkunde, 58(4), 1998, pp. 225-227
Authors:
COSTA SD
DIEL IJ
VONMINCKWITZ G
SCHARL A
KAUFMANN M
Citation: Sd. Costa et al., COMMENT ON CLINICAL RESEARCH IN GERMANY A S EXEMPLIFIED BY GYNECOLOGICAL ONCOLOGY - POINTERS ON HOW TO GET OUT OF A CUL-DE-SAC DILEMMA, Geburtshilfe und Frauenheilkunde, 58(3), 1998, pp. 133-138
Authors:
SCHOMACKER K
HEBRANK H
SCHEIDHAUER K
SCHARL A
SACCAVINI JC
SHUKLA SK
FRANKE WG
SCHICHA H
Citation: K. Schomacker et al., INFLUENCE ON EXTRATUMORAL ORGAN ACTIVITIE S OF TUMOR-AFFINE SAMARINM-153-PREPARATIONS, Nuklearmedizin, 36(2), 1997, pp. 47-51
Authors:
VONMINCKWITZ G
HEIDEMANN E
SOUCHON R
SAMONIGG H
HIRSCHMANN WD
BODENSTEIN H
SCHINDLER A
SCHULZE M
CLEMENS H
KONIG M
SCHARL A
FISCHER JT
KAUFMANN M
Citation: G. Vonminckwitz et al., MITOXANTRONE (N) VS. 5-FLUOROURACIL EPIRUBICIN/CYCLOPHOSPHAMIDE (FEC)AS FIRST LINE THERAPY IN HIGH-RISK METASTATIC BREAST-CANCER/, European journal of cancer, 33, 1997, pp. 646-646
Authors:
WAGNER M
BOABANG P
LEYSSENS N
GUENTHER A
MUELLER S
GOEHRING UJ
SCHARL A
PFISTER H
MALLMANN P
KRUEGER GRF
Citation: M. Wagner et al., NUMERIC ABERRATIONS OF P53 GENE BEARING CHROMOSOME-17 IN HUMAN PAPILLOMAVIRUS-ASSOCIATED INVASIVE CERVICAL-CANCER, The FASEB journal, 11(3), 1997, pp. 586-586
Authors:
SCHOMACKER K
LOHR H
SCHARL A
SCHEIDHAUER K
LIEBENHOFF S
SALDITT S
SCHICHA H
Citation: K. Schomacker et al., COMPARISON OF TC-99M-MIBI, TC-99M-TETROFOSMIN, TC-99M-Q-12 AND TL-201- BIOKINETICS ON TUMOR-BEARING MICE, The Journal of nuclear medicine, 38(5), 1997, pp. 1019-1019
Authors:
ENGEL H
KLEESPIES C
SCHARL A
FRIEDRICH J
SCHONDORF T
KOLHAGEN H
MALLMANN P
Citation: H. Engel et al., DETECTION OF CIRCULATING TUMOR-CELLS IN PATIENTS WITH BREAST OR OVARIAN-CANCER BY MOLECULAR CYTOGENETICS, Blood, 90(10), 1997, pp. 3570-3570
Authors:
AHR A
ARNOLD G
GOHRING UJ
COSTA S
SCHARL A
GAUWERKY JFH
Citation: A. Ahr et al., CYTOLOGY OF ASCITIC FLUID IN A PATIENT WITH METASTASIZING MALIGNANT BRENNER TUMOR OF THE OVARY - A CASE-REPORT, Acta cytologica, 41(4), 1997, pp. 1299-1304
Authors:
TUTSCHEK B
NIEDERACHER D
CAMINADA MC
GOHRING UJ
SCHARL A
SCHNURCH HG
BECKMANN MW
BENDER HG
Citation: B. Tutschek et al., PS2 PROTEIN DETECTED BY IMMUNOHISTOCHEMISTRY IN ARCHIVAL PRIMARY BREAST-CANCER - PROGNOSTIC VALUE AND LONG-TERM FOLLOW-UP IN 219 PATIENTS, Oncology Reports, 3(4), 1996, pp. 759-764
Authors:
AHR A
GOHRING UJ
SCHARL A
TITIUS BR
CROMBACH G
Citation: A. Ahr et al., CORRELATION BETWEEN THE EXPRESSION OF THE ESTROGEN-DEPENDED PS2-PROTEIN AND PROGNOSIS, Tumordiagnostik & Therapie, 17(6), 1996, pp. 182-187
Authors:
SCHEIDHAUER K
SCHARL A
PIETRZYK U
WAGNER R
GOHRING UJ
SCHOMACKER K
SCHICHA H
Citation: K. Scheidhauer et al., QUALITATIVE [F-18] FDG POSITRON EMISSION TOMOGRAPHY IN PRIMARY BREAST-CANCER - CLINICAL RELEVANCE AND PRACTICABILITY, European journal of nuclear medicine, 23(6), 1996, pp. 618-623
Authors:
GOHRING UJ
SCHARL A
THELEN U
AHR A
CROMBACH G
TITIUS BR
Citation: Uj. Gohring et al., PROGNOSTIC VALUE OF CATHEPSIN-D IN BREAST-CANCER - COMPARISON OF IMMUNOHISTOCHEMICAL AND IMMUNORADIOMETRIC DETECTION METHODS, Journal of Clinical Pathology, 49(1), 1996, pp. 57-64
Authors:
SCHARL A
SCHEIDHAUER K
PIETRZYK U
GOHRING UJ
SCHOMACKER K
Citation: A. Scharl et al., DETECTION OF MULTIFOCAL BREAST-CARCINOMA BY 2[F-18]FLUORODEOXY-D-GLUCOSE POSITRON-EMISSION-TOMOGRAPHY (FDG-PET), Geburtshilfe und Frauenheilkunde, 56(8), 1996, pp. 434-437
Authors:
GOHRING UJ
SCHARL A
AHR A
Citation: Uj. Gohring et al., IMMUNOHISTOCHEMICAL DETECTION OF RECEPTOR S, PROTEASES, TUMOR-SUPPRESSOR PROTEINS AND PROLIFERATING MARKERS AS PROGNOSTIC INDICATORS FOR PRIMARY BREAST-CANCER PATIENTS, Geburtshilfe und Frauenheilkunde, 56(4), 1996, pp. 177-183
Authors:
SCHOMACKER K
HIENTZSCH B
FRANKE WG
SCHEIDHAUER K
SCHARL A
JANTSCH K
SHUKLA SK
LIMOURIS G
FISCHER T
SCHICHA H
Citation: K. Schomacker et al., STUDIES ON THE BIOKINETICS OF TUMOR-AFFIN E YTTRIUM PREPARATIONS .2., Nuklearmedizin, 34(5), 1995, pp. 207-214
Authors:
SCHOMAKER K
HIENTZSCH B
FRANKE WG
SCHEIDHAUER K
SCHARL A
JANTSCH K
SHUKLA SK
LIMOURIS G
SCHICHA H
Citation: K. Schomaker et al., STUDIES ON THE BIOKINETICS OF TUMOR-AFFIN E YTTRIUM PREPARATIONS .1., Nuklearmedizin, 34(1), 1995, pp. 32-39
Authors:
GOHRING UJ
AHR A
SCHARL A
WEISNER V
NEUHAUS W
CROMBACH G
HOLT JA
Citation: Uj. Gohring et al., IMMUNOHISTOCHEMICAL DETECTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR LACKS PROGNOSTIC-SIGNIFICANCE FOR BREAST-CARCINOMA, Journal of the Society for Gynecologic Investigation, 2(4), 1995, pp. 653-659
Authors:
GOHRING UJ
SCHARL A
HECKEL C
AHR A
CROMBACH G
Citation: Uj. Gohring et al., P53 PROTEIN IN 204 PATIENTS WITH PRIMARY BREAST-CARCINOMA - IMMUNOHISTOCHEMICAL DETECTION AND CLINICAL-VALUE AS A PROGNOSTIC FACTOR, Archives of gynecology and obstetrics, 256(3), 1995, pp. 139-146
COMPARISONS OF RADIOIODOESTRADIOL BLOOD-TISSUE EXCHANGE AFTER INTRAVENOUS OR INTRAARTERIAL INJECTION
Authors:
SCHARL A
BECKMANN MW
ARTWOHL JE
HOLT JA
Citation: A. Scharl et al., COMPARISONS OF RADIOIODOESTRADIOL BLOOD-TISSUE EXCHANGE AFTER INTRAVENOUS OR INTRAARTERIAL INJECTION, International journal of radiation oncology, biology, physics, 32(1), 1995, pp. 137-146
Authors:
GOHRING UJ
SCHARL A
THELEN U
AHR A
TITIUS BR
Citation: Uj. Gohring et al., PROGNOSTIC-SIGNIFICANCE OF IMMUNOHISTOCHE MICAL DETECTION OF UROKINASE PLASMINOGEN-ACTIVATOR IN PRIMARY BREAST CARCINOMAS, Der Pathologe, 16(6), 1995, pp. 398-403
Authors:
AHR A
SCHARL A
GOHRING UJ
CROMBACH G
STOFFL M
Citation: A. Ahr et al., IMMUNOHISTOCHEMICAL DEMONSTRATION OF THE PS2 PROTEIN USING PARAFFIN SECTIONS OF MAMMARY-CARCINOMA TISSUE - COMPARISON WITH THE RESULTS OF AN IMMUNORADIOMETRIC ASSAY, Der Pathologe, 16(4), 1995, pp. 278-284
Authors:
TITIUS BR
GOHRING UJ
SCHARL A
Citation: Br. Titius et al., BILATERAL MAMMARY-CARCINOMA FOLLOWING MYX OID LIPOSARCOMA OF THE BREAST, Der Pathologe, 16(3), 1995, pp. 230-234